title: Thioacetamide-induced Hepatocellular Necrosis Is Attenuated in Diet-induced Obese Mice.
abstract: To assess modification of thioacetamide-induced hepatotoxicity in mice fed a high-fat diet, male C57BL/6J mice were fed a normal rodent diet or a high-fat diet for 8 weeks and then treated once intraperitoneally with thioacetamide at 50 mg/kg body weight. At 24 and 48 hours after administration, massive centrilobular hepatocellular necrosis was observed in mice fed the normal rodent diet, while the necrosis was less severe in mice fed the high-fat diet. In contrast, severe swelling of hepatocytes was observed in mice fed the high-fat diet. In addition, mice fed the high-fat diet displayed more than a 4-fold higher number of BrdU-positive hepatocytes compared with mice fed the normal rodent diet at 48 hours after thioacetamide treatment. To clarify the mechanisms by which the hepatic necrosis was attenuated, we investigated exposure to thioacetamide and one of its metabolites, the expression of CYP2E1, which converts thioacetamide to reactive metabolites, and the content of glutathione S-transferases in the liver. However, the reduced hepatocellular necrosis noted in mice fed the high-fat diet could not be explained by the differences in exposure to thioacetamide or thioacetamide sulfoxide or by differences in the expression of drug-metabolizing enzymes. On the other hand, at 8 hours after thioacetamide administration, hepatic total glutathione in mice fed the high-fat diet was significantly lower than that in mice fed the normal diet. Hence, decreased hepatic glutathione amount is a candidate for the mechanism of the attenuated necrosis. In conclusion, this study revealed that thioacetamide-induced hepatic necrosis was attenuated in mice fed the high-fat diet.
authors.affiliation: Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., 717 Horikoshi, Fukuroi, Shizuoka 437-0065, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Shirai
authors.forename: Shingo
authors.initials: S
authors.lastname: Arakawa
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Miida
authors.forename: Takuya
authors.initials: T
authors.lastname: Matsuyama
authors.forename: Junzo
authors.initials: J
authors.lastname: Kinoshita
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Makino
authors.forename: Kiyonori
authors.initials: K
authors.lastname: Kai
authors.forename: Munehiro
authors.initials: M
authors.lastname: Teranishi
keywords: high-fat diet; liver; mouse; nonalcoholic fatty liver disease; obese; thioacetamide
references.citation: J Cell Biol. 1992 Nov;119(3):493-501
references.pmid: 1400587
references.citation: Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
references.pmid: 16447287
references.citation: Br J Nutr. 2008 Jan;99(1):37-43
references.pmid: 17651528
references.citation: Hepatology. 1995 May;21(5):1465-8
references.pmid: 7737654
references.citation: Toxicology. 2006 Feb 15;219(1-3):175-86
references.pmid: 16368179
references.citation: Endocr Rev. 2007 Feb;28(1):48-83
references.pmid: 17018838
references.citation: Toxicol In Vitro. 2010 Dec;24(8):2097-103
references.pmid: 20600801
references.citation: Biochem J. 2009 Jan 1;417(1):183-93
references.pmid: 18752470
references.citation: Drug Metab Rev. 2011 Aug;43(3):317-34
references.pmid: 21612324
references.citation: Mol Pharmacol. 1983 Jan;23(1):219-27
references.pmid: 6408387
references.citation: Hepatology. 2005 Nov;42(5):1148-57
references.pmid: 16231352
references.citation: Am J Pathol. 1991 Nov;139(5):1099-109
references.pmid: 1683163
references.citation: Toxicology. 2007 Feb 12;230(2-3):105-16
references.pmid: 17187915
references.citation: Science. 2011 Jun 24;332(6037):1519-23
references.pmid: 21700865
references.citation: J Bioenerg Biomembr. 2011 Feb;43(1):19-23
references.pmid: 21258853
references.citation: J Hepatol. 2006 Feb;44(2):368-74
references.pmid: 16140414
references.citation: Anal Biochem. 1981 Apr;112(2):195-203
references.pmid: 6266278
references.citation: J Biol Chem. 1974 Nov 25;249(22):7130-9
references.pmid: 4436300
references.citation: Toxicol Appl Pharmacol. 2008 May 1;228(3):295-300
references.pmid: 18374380
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Gut. 2001 Jan;48(1):34-40
references.pmid: 11115820
references.citation: Drug Metab Dispos. 2005 Dec;33(12):1877-85
references.pmid: 16183780
references.citation: Microcirculation. 2006 Jan;13(1):19-27
references.pmid: 16393943
references.citation: Exp Toxicol Pathol. 2007 Nov;59(3-4):157-62
references.pmid: 17826083
references.citation: Obesity (Silver Spring). 2006 Aug;14(8):1294-302
references.pmid: 16988071
references.citation: J Gastroenterol Hepatol. 2010 Mar;25(3):635-43
references.pmid: 20370733
references.citation: FASEB J. 2003 Jan;17(1):64-6
references.pmid: 12424221
references.citation: J Pharmacol Exp Ther. 2000 Aug;294(2):473-9
references.pmid: 10900221
references.citation: Toxicology. 2010 Feb 9;268(3):204-12
references.pmid: 20036707
references.citation: Arch Toxicol. 2003 Mar;77(3):131-7
references.pmid: 12632252
references.citation: Clin Sci (Lond). 2004 Mar;106(3):261-8
references.pmid: 14556645
references.citation: Toxicol Pathol. 2011 Oct;39(6):949-57
references.pmid: 21885874